V
ertical HIV infection remains a substantial public health concern with nearly 2 million children living with HIV infection worldwide. 1 Despite proven interventions to prevent vertical HIV transmission, new cases of pediatric HIV continue to occur while the existing population of HIV-infected children is growing older and reaching adolescence. [2] [3] [4] A major gap exists in our understanding of the neurodevelopmental outcomes in vertically infected individuals. This is particularly true regarding measures of brain integrity, as regions of the world that shoulder the burden of pediatric HIV often do not have access to neuroimaging methods and standardized neuropsychologic measures to support controlled investigations of pediatric brain function.
Neuroimaging studies focused on adults with chronic HIV infection generally reveal subcortical brain atrophy and reduced total brain volumes. [5] [6] [7] [8] [9] [10] Fewer neuroimaging studies have focused on children with vertical HIV infection, and the outcomes are not consistent. Cohen et al 11 reported reduced volumes of total gray and total white matter, increased white matter lesions and reduced white matter microstructural integrity in HIV-infected children when compared with demographically similar controls. Volumes of subcortical gray matter nuclei did not differ between groups, and brain volumes did not correlate with cognitive performance in the HIVinfected sample. A different neuroimaging signature was recently reported by Sarma et al 12 using voxel-based morphometry in a sample of HIV-infected children. Results revealed larger subcortical gray matter volume and smaller white matter volumes in the HIVinfected sample, with no differences between groups in total gray or total white matter volumes. The present study was conducted to further clarify the neuroimaging phenotype of pediatric HIV, using both regional and global indices of structural brain volumes. Neuropsychologic performances were measured as functional correlates of brain integrity. Given the lack of consistent outcomes in previous studies, 11, 12 directional hypotheses were not determined, and therefore, 2-tailed hypothesis testing was completed.
METHODS

Participants
The present study included 101 Thai children (51 HIV infected and 50 HIV uninfected) of 6-17 years of age (mean: 11.4 ± 2.5), enrolled in the neuro substudy of the Pediatric Randomized Early versus Deferred Initiation in Cambodia and Thailand (PREDICT) cohort. 13 PREDICT enrolled 300 antiretroviral therapy (ART)-naive children (<18 years of age) between 2006 and 2008. By protocol, eligible HIV-infected children from Thailand (n = 180) and Cambodia (n = 120) were randomized to early (ART initiation at CD4 15%-24%) versus deferred (ART initiation at CD4 <15%) treatment for 144 weeks. Children enrolled into PREDICT were ART naive, per national treatment guidelines at the time of the study (CD4 % <15% or AIDS-defining illness), until randomization at a median age of 6.5 years [interquartile range (IQR): 3.9-8.4].
The neuro substudy of PREDICT 14 began several years after the start of the main PREDICT trial. We included only those children with neuroimaging [structural magnetic resonance imaging (MRI)], neuropsychologic testing and laboratory assays [T cells, viral load (VL)]. MRI was not available in Cambodia; therefore, only Thai children were enrolled in the neuro substudy. PREDICT 13 and the neuro substudy 14 were approved by the relevant institutional review boards. Caregivers provided written consent and children 8 years of age and older provided assent to participate in both studies per local ethics requirements. Most (31/51) of the HIV-infected children included in the present study were enrolled in the early treatment arm of PREDICT. These children were on ART for a median of 34 months (range: 33-42 months), with HIV RNA <40 copies/mL in 89% of the children, median log VL of 1.6 [IQR: 1.6-1.6, minimum-maximum (minmax): 1.3-3.8] and median CD4 count of 853 (IQR: 637-942, minmax: 470-1443). First-line ART included zidovudine, lamivudine and nevirapine; children unable to take nevirapine received efavirenz or lopinavir-ritonavir. The remaining 20 HIV-infected children were enrolled in the deferred arm of PREDICT and reported a median log VL of 4.1 (IQR: 2.3-4.7, min-max: 1.3-5.4) and median CD4 count of 352 cells/mm 3 (IQR: 255-400, min-max: 66-625). Exclusion criteria for the HIV-infected group included the following: (1) previous or current brain infection; (2) neurologic or psychiatric disorder known to affect brain integrity; (3) congenital abnormalities; (4) previous use of immunomodulators within the past month of enrollment and (5) abnormal laboratory tests including absolute neutrophil count <750 cells/mL, hemoglobin <7.5 g/dL, platelet counts <50,000/mL or alanine aminotransferase >4 times the upper limit of normal levels. Demographically similar HIV-uninfected children were recruited from siblings of the HIV-infected children and local well-child clinics following the same inclusion/exclusion criteria. The HIV-uninfected control group comprised of 2 subgroups including HIV-exposed but uninfected children (n = 24) and HIV-unexposed children (n = 26). We previously reported no significant differences in brain imaging indices between these 2 groups 15 ; therefore, we collapsed the 2 samples into 1 control group for the present study.
Neuroimaging Acquisition and Analyses
Whole-brain structural T1-weighted MRI was performed on GE 1.5 tesla scanners (General Electric Healthcare, Milwaukee, WI. 1.5 Tesla) at Chulalongkorn University Hospital in Bangkok and Chiang Mai University Hospital in Chiang Mai, Thailand. The structural imaging used the following protocol: axial plane, 3D Spoiled gradientrecalled echo (SPGR) images with a minimum TE at full echo, TR = 11.2 ms, slice thickness = 1.0 mm; 256 × 256 imaging matrix. Volumetric analyses were conducted on the structural scans acquired at week 144 for the early treatment arm and approximately 4 weeks after starting treatment for the 15 children enrolled in the deferred arm. Brain volumes were determined from the T1-weighted images following a standardized approach to quantify regional and global anatomical structures. The Functional MRI of the Brain Software image processing library was used to run Functional Magnetic Resonance Imaging of the Brain's Integrated Registration and Segmentation Tool (FIRST), a tissue segmentation protocol, which also performs intensity inhomogeneity correction. These images were then processed with FreeSurfer. 16 Enhancing Neuro Imaging Genetics through Meta Analysis (ENIGMA) protocols 17 were used to extract volumetric measures from FreeSurfer outputs and perform visual and statistical quality control assessments. Extracerebral tissue was removed from anatomical scans using the brain extraction tool 18 from the Oxford Centre for Functional MRI of the Brain Software Library (www.fmrib.ox.ac.uk/fsl). Regions of interest included the following: caudate, putamen, pallidum, amygdala, nucleus accumbens, hippocampus, total white matter, total gray matter and cortical gray matter. Intracranial volume was included as a covariate in the statistical analyses.
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Neuropsychologic Assessment
Participants completed a standardized neuropsychologic battery sensitive to pediatric HIV. 14 The battery comprised of the following measures:
Intelligence: Verbal intelligence quotient (VIQ) and performance intelligence quotient (PIQ) from the Thai version the Wechsler Intelligence Scale for Children-third edition (WISC-III, 6-17 years of age). Attention/short-term memory: Digit span from the WISC-III and memory for beads/sentences (5-17 years of age) and memory for digits/objects (6-17 years of age) from the Stanford-Binet. Working memory/executive function: Similarities and arithmetic subtests from the WISC-III and Child Color Trails Test 2 (Color Trails 2; 8-17 years of age). Psychomotor: The Beery visual motor integration scale (5-17 years of age), symbol search and coding from the WISC-III (6-17 years of age), Child Color Trails Test 1 (Color Trails 1; 8-17 years of age) and Purdue Pegboard average pin placements of the dominant and nondominant hand (6-17 years of age). Standardized scores were used for the WISC-III measures, and raw scores were used for the other neuropsychologic tests.
Laboratory Variables
Laboratory measures of HIV disease activity and immunologic status were obtained through standard blood assays. Dependent measures included CD4 and CD8 cell count, VL and CD4/CD8 ratio. Clinical laboratory procedures were approved by National Institute of Allergy and Infectious Diseases-Division of AIDS (NIAID-DAIDS) and passed annual quality assurance programs of the UK National External Quality Assessment Service and Mahidol University, Bangkok, Thailand. Additional laboratory information is available in the online repository.
Statistical Analysis
Analyses were conducted with STATA 14.1 (StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP). 20 Chi square or Fisher exact tests and independent t tests, as appropriate, were conducted to examine differences between the HIV-infected and HIV-uninfected groups on age, sex, child's educational level and caregiver's educational level, household income and child's living situation. Linear regression models were employed to calculate unadjusted mean differences in regional brain volumes and neuropsychologic test scores between groups. Regional brain volume analyses were adjusted for age, sex and intracranial volume, and income in univariate models. Only household income was included in the adjusted models for VIQ and PIQ because these scores represent demographically standardized scores. A factor analysis was completed to consolidate the individual neuropsychologic tests into separate cohesive domains, and the resulting factors were included as the primary neuropsychologic outcomes in the subsequent analyses. This method provides a data-driven approach to limit the number of comparisons and reduce the frequency of chance findings.
RESULTS
Demographic and Clinical Characteristics
The HIV-infected and uninfected children did not differ statistically in age (P = 0.15). However, the HIV-infected children were nearly 1 year older than the HIV-uninfected children [mean difference: −0.7, 95% confidence interval (CI): −1.7 to 2.7]; therefore, we included age into the adjusted models as a conservative approach. The HIV-infected and uninfected groups were similar in sex, child's school grade and caregiver's educational levels (Table 1) . Twelve (24%) HIVinfected children but no HIV-uninfected children lived in orphanages (P < 0.01) and a higher proportion of HIV-uninfected children had above-average household incomes, while a higher proportion of HIVinfected children had below-average income (P = 0.007). Because all the children in the orphanages had below-average household income, we adjusted for income but not living arrangement where appropriate.
Neuroimaging Comparisons between HIV-infected and HIV-uninfected Children
Results of the adjusted models revealed larger brain volumes in HIV-infected children compared with the HIV-uninfected children in the caudate, nucleus accumbens and total gray matter. A similar trend (P = 0.06-0.07) was observed in the putamen, pallidum and amygdala (Table 2 ). Secondary analyses revealed that larger brain volumes were most pronounced in children <12 years of age. These younger children had significantly larger volumes of the caudate, pallidum and amygdala when compared with the HIVuninfected children <12 years of age. By contrast, no differences in brain volumes were observed between groups comprised of children 12 years of age and older.
Neuropsychologic Comparisons Between HIVinfected and HIV-uninfected Children
In adjusted analyses, the HIV-infected group performed significantly worse than HIV-uninfected children on VIQ and PIQ, similarities, arithmetic, memory for sentences, memory for beads, memory for objects, symbol search, coding and Beery visual motor integration scale (Ps ≤ 0.01) ( Table 3 ). The HIV-infected group performed better than the HIV-uninfected group on the Pegboard test though the difference was clinically negligible. Performances on digit span, Color Trails 1 and Color Trails 2 did not differ by group.
Correlations Between Neuropsychologic Performance and Neuroimaging Outcomes
Brain volumes did not correspond to neuropsychologic performances (factors) among the HIV-infected children (see Table 4 for the factor loadings). In the HIV-uninfected group, positive correlations were observed between thalamic volume and both working memory/executive function (ρ = 0.392, P < 0.01) and attention/ short-term memory (ρ = 0.368, P < 0.01) ( Fig. 1 and Table 5 ).
Relationships Between Laboratory, Neuropsychologic and Neuroimaging Indices
Neither neuroimaging indices nor neuropsychologic performances covaried with CD4 count or CD4/CD8 ratio. However, 
DISCUSSION
The present study helps to clarify the neuroimaging profile of children with vertical HIV infection. Using robust and standardized volumetric methods, we identified larger volumes of subcortical brain regions, cortical gray matter and total gray matter in HIV-infected children compared with HIV-uninfected controls, with the most pronounced effects evident in younger children. Significant differences in brain volumes remained after controlling for the potential impact of socioeconomic and demographic factors. HIV-infected children also performed worse than controls on most neuropsychologic tests. Cognitive status corresponded to brain volumes in the uninfected but not the HIV-infected children. These results provide novel evidence of brain imaging and neuropsychologic abnormalities among young HIV-infected children with clade CRF01_AE disease, the dominant genetic viral clade in Southeast Asia. 21 Interpretation of the neuroimaging signature described in the present study must consider the selection of the sample, defined by HIV-infected children who had survived early childhood (mean age of 6 years at randomization) without having met clinical criteria at the time to initiate ART. These children represent survivors, and it is possible that resilience factors influenced the neuroimaging phenotype described in this sample of children. Unique to this sample, most HIV-children exhibited a high nadir CD4 and were virologically suppressed after ART. Additionally, it is important to note that differences in brain volumes may reflect uncontrolled variance because of developmentally relevant differences in age rather than disease-specific mechanisms. Our adjusted regression models included age as a covariate, yet it is possible that statistical corrections are not sufficient controls for the inherent variability in pediatric brain volumes, particularly in the absence of age-specific morphometric templates. 22, 23 With these caveats noted, our finding of larger brain volumes in HIVinfected children aligns with previous outcomes reporting deleterious effects of vertical HIV transmission on brain integrity.
12 FIGURE 1. Scatter plots with line of best fit for the correlation between thalamic volume and the working memory/ executive function factor score (A), thalamic volume and the attention/short-term memory function factor score (B), ICV and the working memory/ executive function factor score (C) and ICV and attention/ short-term memory factor score (D) in HIV-uninfected children. ICV indicates intracranial volume. HIV infection during fetal development and/or early childhood might disrupt neurodevelopmental processes that ultimate govern or influence brain volume. Under conditions of healthy brain development, the volume of subcortical gray matter increases until early adolescence at which point volumetric decline occurs due to programmed neuronal pruning. [24] [25] [26] Prior work has suggested that larger brain volumes in pediatric populations with various medical conditions reflect abnormalities in the pruning mechanisms. 27, 28 However, selective pruning of the neuronal architecture typically begins at the onset of adolescence (approximately 12 years of age), 24 and our secondary analyses revealed that HIV-infected children <12 years of age exhibited the most pronounced differences in brain volumes compared with HIV-uninfected controls. As such, it is unlikely that abnormal pruning accounts for the larger brain sizes observed in the present study.
Previous studies report larger subcortical gray matter and reduced cortical white matter in pediatric HIV, 12 whereas other studies report no differences in subcortical volumes but more pronounced atrophy of total gray and total white matter in this population. 6 In the present study, white matter volume did not differ by infection status in either adjusted or unadjusted statistical models. Additional investigations focused on select white matter tracts and Magnetic resonance (MR) diffusion metrics examined over a multiyear period would allow a more complete examination of the relationship between HIV and developmental stage. Prior studies using diffusion tensor imaging reveal microstructural white matter abnormalities in vertically infected children, including individuals on ART and individuals with slow progressive disease. [29] [30] [31] Additional investigations using diffusion tensor imaging and related approaches such as diffusion-based spectral imaging 32 will facilitate a more complete understanding of the brain connectome in children with vertically infected HIV.
We observed worse neuropsychologic performance among the HIV-infected children in the context of ART-mediated viral suppression. Preliminary work from other studies suggests that sustained CD4 depletion is not mandatory for the expression of cognitive symptoms in vertically infected children. Hoare et al 29 reported significantly lower VIQ and PIQ scores and worse performance on tests of executive function, visuospatial processing and visual learning and memory among HIV-infected children who were ART naive with CD4 >25%. Similarly, Ruel et al 33 identified worse performance on tests of attention, motor function and intelligence among treatment-naive HIV-infected Ugandan children with CD4 cell counts >350 cells/mm 3 compared with controls. Higher plasma HIV RNA was associated with poorer performance on numerous cognitive measures, and the pattern remained unchanged when analyses were restricted to individuals with World Health Organization clinical stage 1 or 2 disease. These studies indicate that clinical interventions and accommodations may be necessary for vertically infected children independent of past or current immunologic status and treatment history.
Several limitations of the present study should be noted. Cerebrospinal fluid levels of immunologic/virologic indices were not available; therefore, the analyses of disease burden focused on peripheral measures. Additionally, conclusions regarding the progression of brain injury are limited by the cross-sectional design employed in this study. Prospective studies are needed to model the evolution of neuropsychologic and neuroimaging abnormalities in HIV-infected children. Outcomes from these additional studies would inform the potential interactions between developmental processes and disruption to brain integrity in both younger and older children.
In summary, we report increased volumes of subcortical and cortical brain regions in children with vertically infected HIV who did not meet clinical criteria to initiate ART until later childhood. HIV-infected children performed worse than HIV-uninfected controls on most neuropsychologic tests, though performances did not correlate with brain volumes. The observation of more pronounced group differences among younger children suggests the involvement of mechanisms other than neuronal pruning. Additional studies are needed to determine whether potential "survivor" characteristics inherent in our sample and related resilience factors influence the neuroimaging signature of pediatric HIV. Finally, longitudinal studies are needed to model the trajectory of brain integrity in the context of sustained viral suppression to determine the functional relevance of residual brain abnormalities in this vulnerable population.
